UNSPSC 51401902: Alpidem

This classification denotes a sedative and hypnotic with the molecular formula C21H23Cl2N3O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I93SC245QZ, chemically known as 6-chloro-2-(p-chlorophenyl)-n,n-dipropylimidazo(1,2-a)pyridine-3-acetamide but generally known as alpidem, which bears US NIH Compound Identifier 54897. European Medicines Agency schedules Alpidem in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05367MIG.

UNSPSC 51401902 Alpidem, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The single recent opportunity in the dataset — Seminole County, Florida's IFB 60459723LAS, posted June 30, 2026 with a response deadline of July 26, 2023 — solicits naloxone and safe drug deactivation systems for community health initiatives, not alpidem, a sedative pharmaceutical. The mismatch between the code's nominal scope and what the county is actually buying suggests either a tagging error or a data anomaly; the opportunity itself is genuine, but does not represent authentic demand under this Commodity code.

The source provides no additional recent opportunities, repeat issuing bodies, or geographic concentration under UNSPSC 51401902. Alpidem procurement through state and local government channels does not appear to be active in the current market or is extremely limited. A business development professional evaluating this code should verify the accuracy of the code assignment with the buying organization before investing pursuit resources.